Benzinga's Top #PreMarket Gainers
January 06, 2015 at 08:12 AM EST
Minerva Neurosciences, Inc.(NASDAQ: NERV) shares rose 58.33% to $9.50 in pre-market trading following positive study results. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.